Considerations for using sucrose to reduce procedural pain in preterm infants

Area of Science:

• Neonatal care
• Developmental neuroscience
• Pain management

Background:

• Neonatal intensive care units (NICUs) involve frequent, painful procedures for preterm and critically ill infants.
• Sucrose is a common, nonpharmacologic pain management tool for these neonates.
• Limited research exists on the long-term neurodevelopmental effects of repeated sucrose administration.

Purpose of the Study:

• To review current literature on sucrose's effects on pain processing and neurodevelopment in infants.
• To explore potential amine and hormone pathways involved in sucrose's mechanism of action.
• To identify gaps in research regarding repeated sucrose use in the NICU.

Main Methods:

• Review of animal models and human infant studies on sucrose and pain.
• Analysis of research on chronic sugar exposure and neurodevelopment.
• Synthesis of findings to propose future research directions.

Main Results:

• Animal studies suggest opioid pathways mediate sucrose's pain-relieving effects.
• Human infant data on sucrose's physiological mechanisms are ambiguous.
• One study linked high daily sucrose doses in the first week to poorer attention and motor development post-NICU discharge.

Conclusions:

• Repeated sucrose use in NICU infants warrants further investigation.
• Understanding sucrose's impact on attention and motor development is crucial.
• Research should focus on both the calming mechanisms and long-term neurodevelopmental outcomes of repeated sucrose exposure.